Abstract:Systemic iron homeostasis is strictly controlled under normal conditions to ensure a balance between the absorption, utilization, storage and recycling of iron. The hepcidin-ferroportin (FPN) axis is of critical importance in the maintenance of iron homeostasis. Hepcidin deficiency gives rise to enhanced dietary iron absorption, as well as to increased iron release from macrophages, and this in turn results in iron accumulation in the plasma and organs, and is associated with a range of tissue pathologies. Low hepcidin levels have been demonstrated in most forms of hereditary hemochromatosis (HH), as well as in β-thalassemia. Therapies that increase hepcidin concentrations may potentially play a role in the treatment of these iron overload-related diseases. To date, natural compounds have not been extensively investigated for this purpose, to the best of our knowledge. Thus, in the present study, we screened natural compounds that have the potential to regulate hepcidin expression. By performing hepcidin promoter-luciferase assay, RT-qPCR and animal experiments, we demonstrated that icariin and berberine were potent stimulators of hepcidin transcription. Mechanistic experiments indicated that icariin and berberine increased hepcidin expression by activating the signal transducer and activator of transcription 3 (Stat3) and Smad1/5/8 signaling pathways. The induction of hepcidin was confirmed in mice following icariin administration, coupled with associated changes in serum and tissue iron concentrations. In support of these findings, the icariin analogues, epimedin A, B and C, also increased hepatic hepcidin expression. However, these changes were not observed in hepcidin-deficient [Hamp1-/- or Hamp1‑knockout (KO)] mice following icariin administration, thereby verifying hepatic hepcidin as the target of icariin. Although berberine exhibited a robust capacity to promote hepcidin expression in vitro, it failed to alter hepcidin expression in mice. Taken together, the findings of the present study suggest that icariin exhibits a robust capacity to increase hepatic hepcidin expression and to modulate systemic iron homeostasis. The present study therefore highlights the significance of using natural compounds to ameliorate iron disorders through the regulation of hepcidin expression.

Application of myricetin in preparing preparation for inhibiting hepcidin expression

Application of black bean and extractive of same in manufacture of preparation for inhibiting expression of hepcidin

The Dietary Flavonoid Myricetin Regulates Iron Homeostasis by Suppressing Hepcidin Expression

Hesperetin Derivative-14 Alleviates Inflammation by Activating PPAR-γ in Mice with CCl4-induced Acute Liver Injury and LPS-treated RAW264.7 Cells.

Application of myricetin in preparing BMP-Smad pathway small-molecule inhibitor

Low anticoagulant heparin-iron complex targeting inhibition of hepcidin ameliorates anemia of chronic disease in rodents

Screening and identification of Caulis Spatholobi as an effective hepcidin inhibitor from Chinese medicinal plants

Advance in Hepcidin

Hepcidin: A Promising Therapeutic Target for Iron Disorders: A Systematic Review.

Icariin Regulates Systemic Iron Metabolism by Increasing Hepatic Hepcidin Expression Through Stat3 and Smad1/5/8 Signaling

Effect of hepcidin antagonists on anemia during inflammatory disorders

Hesperetin Derivative Attenuates CCl4-induced Hepatic Fibrosis and Inflammation by Gli-1-dependent Mechanisms.

Screening Identifies the Chinese Medicinal Plant Caulis Spatholobi As an Effective HAMP Expression Inhibitor1–3

Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis

Activation of Intestinal HIF2α Ameliorates Iron-Refractory Anemia

Direct and macrophage stimulation mediated effects of active, inactive, and cell-free supernatant forms of Akkermansia muciniphila and Faecalibacterium duncaniae on hepcidin gene expression in HepG2 cells

Molecular mechanisms and therapeutic implications of dihydromyricetin in liver disease

Myricetin Induces Apoptosis and Protective Autophagy through Endoplasmic Reticulum Stress in Hepatocellular Carcinoma

Study on Dihydromyricetin Improving Aflatoxin Induced Liver Injury Based on Network Pharmacology and Molecular Docking

Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota

Study on the synthesis of iron-based nanomedicine assisted by angelica sinensis polysaccharide with enhanced retention performance and its application in anemia treatment